The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
NCT06287593
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
300
Enrollment
OTHER
Sponsor class
Conditions
EGF-R Positive Non-Small Cell Lung Cancer
Interventions
OTHER:
ctDNA monitoring
Sponsor
Zhejiang University